James M. Golubieski, Foundation Venture

James M. Golubieski, president of Foundation Venture Capital Group. See sector focus and contact routes.

About James M. Golubieski

James M. Golubieski, president of Foundation Venture Capital Group, invests exclusively in pre-seed and seed-stage health-related technology companies, typically providing $175,000 to $500,000 per deal. His distinctive thesis focuses on commercializing intellectual property from faculty at the University of Medicine and Dentistry of New Jersey (UMDNJ), targeting life sciences such as stem cell therapies for spinal cord injuries, cancer diagnostics, and Alzheimer’s blood tests. Notable portfolio companies include Celvive (spinal cord injury treatment), Actinobac Biomed (hematological malignancies), CellXplore (cancer diagnostics), and Durin Technologies (Alzheimer’s diagnosis).

James M. Golubieski at a glance

Role
President
Organization
Foundation Venture Capital Group
Location
New Brunswick, NJ
Investor type
Venture Capital
Focus areas
Early Stage VC, Seed Round

Frequently asked about James M. Golubieski

What does James M. Golubieski invest in?
James M. Golubieski at Foundation Venture Capital Group (New Brunswick, NJ) — sector focus: Early Stage VC, Seed Round.
How do I contact James M. Golubieski?
James M. Golubieski's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is James M. Golubieski based?
James M. Golubieski is based in New Brunswick, NJ.

This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New Brunswick.

Investors similar to James M. Golubieski (20)

Browse related investor lists (2)

Compare James M. Golubieski (8)

Investors like James M. Golubieski · Full investor directory · Investor access · Company funding database